The 17th Seoul International Symposium and the 98th Korean Society of Obstetrics and Gynecology were held on October 4th-6th at the Grand Hilton Seoul hotel.

This time, the Seoul International Symposium, an international Obstetrics and Gynecology society aimed at improving the quality of women healthcare through information exchanges and discussions, was held together with the fall conference of the Korean Society of Obstetrics and Gynecology.

At this conference, Seegene focused on introducing Anyplex™ II HPV28 Detection that can identify 19 HPV (Human Papilloma Virus) genotypes known as primary causes of cervical cancer and 9 low-risk HPV genotypes that are not highly  associated with cervical cancer but cause sexually transmitted diseases such as genital warts. Anyplex™ II HPV28 Detection also provide the quantitative information of infection from  a single sampling .

As reported, not all of HPV types cause cancer, however, it is only when certain high-risk and low-risk types of HPV that remains in the body and cause cancers.  Seegene’s product drew attention for its usefulness in tracking tests periodically for patients who are infected with high-risk genotypes that have a significant chace of developing cervical cancer   and  ability to  genotype and provide quatitatve information.